Also known as: Nicotinamide mononucleotide, NAD+ precursor, β-NMN
FoundationalEmerging evidence
A precursor to NAD+, the coenzyme central to cellular energy metabolism, and one of the most discussed compounds in longevity research. Human trials are accumulating but remain early, and its regulatory position has shifted in several markets.
Typical dose
250.0–1000.0 mg per day
Morning, with or without food
What it is
Nicotinamide mononucleotide is a nucleotide derived from ribose and nicotinamide, occurring naturally in small amounts in foods such as broccoli, avocado and edamame. Dietary quantities are far below supplemental doses.
Its significance lies in being one step from NAD+, nicotinamide adenine dinucleotide, a coenzyme required for hundreds of metabolic reactions. NAD+ levels decline with age across tissues, and the central hypothesis of this category is that restoring them addresses aspects of that decline.
NMN competes with nicotinamide riboside, or NR, which sits one step further back in the same pathway. Which is superior is genuinely unresolved, with advocates on both sides and no decisive head-to-head human evidence. Anyone claiming certainty here is ahead of the data.
How it works
NMN is converted to NAD+ by the enzyme nicotinamide mononucleotide adenylyltransferase. NAD+ then serves as an electron carrier in glycolysis and oxidative phosphorylation, making it fundamental to cellular energy production.
Beyond energy metabolism, NAD+ is consumed as a substrate by sirtuins, a family of enzymes involved in DNA repair and metabolic regulation, and by PARP enzymes involved in DNA damage response. Because these enzymes consume NAD+ rather than merely using it catalytically, availability constrains their activity.
A genuine open question concerns absorption. Whether NMN is taken up intact via a specific transporter, or first broken down to nicotinamide riboside and reassembled, has been debated in the literature, and the answer bears directly on whether NMN offers any advantage over cheaper precursors.
What the evidence shows
Animal research is extensive and often striking, with reported improvements in metabolic function, vascular health and physical capacity in aged mice. This body of work generated most of the enthusiasm around the compound.
Human trials have accumulated over recent years and generally confirm two things: NMN raises blood NAD+ levels in a dose-dependent way, and it is well tolerated. Beyond that, findings on functional outcomes such as walking capacity, muscle insulin sensitivity and fatigue measures are modest, mixed and generally from small trials.
The honest position is that raising NAD+ is demonstrated, while translating that into meaningful health outcomes in humans is not. The gap between the mouse literature and the human literature is unusually wide here, and marketing generally reports the former.
Dosing
Common supplemental range is 250-1,000 mg daily. Human trials have used doses across this range, with blood NAD+ increases observed in a dose-dependent fashion.
Usually taken in the morning, on the rationale that NAD+ follows a circadian pattern, though evidence for timing is thin.
Purity is worth verifying. Independent testing of this category has found products with less NMN than declared, and the compound is not cheap to manufacture, so unusually low prices warrant scepticism. Sublingual forms are marketed on absorption grounds but the supporting evidence is limited.
At a glance
Common forms
NMN powder, Capsules, Sublingual NMN, Liposomal NMN, Combined with resveratrol
Half-life / duration
Blood NAD+ elevation develops over days to weeks of consistent dosing
Timing
Morning, with or without food
Competition status
Permitted — not on the WADA Prohibited List
Category
Foundational
Safety and side effects
Human trials to date have reported NMN as well tolerated at doses up to 1,000 mg daily, with no consistent pattern of adverse effects. Occasional reports include nausea, headache and digestive discomfort.
Long-term safety data is limited, which matters more than usual for a compound taken indefinitely. Trials have generally run weeks to months rather than years.
Because rapidly dividing cells have high NAD+ demand, anyone receiving medical treatment should discuss it with their doctor rather than assume a longevity supplement is neutral alongside it.
Who should avoid it
Speak to your doctor before use if you are receiving any form of medical treatment or take regular medication. Not established for use in pregnancy or breastfeeding. Long-term safety beyond months of use has not been established.
This entry is provided for information only. Food supplements should not be used as a substitute for a varied and balanced diet and a healthy lifestyle. Consult a qualified healthcare professional before use if you are pregnant, breastfeeding, taking medication or under medical supervision.
